Incidence of clinically relevant psychiatric symptoms during glioblastoma treatment: an exploratory study.
L K P RegliS M H HuijsR C O S PasmansC LeueJ B DijkstraD B P EekersK E HovingaM H M E AntenA HoebenMartinus P G BroenPublished in: Journal of neuro-oncology (2023)
The found incidence of 11.5% and the high number of patients discontinuing treatment due to psychiatric symptoms justify more research in this, to date, understudied topic in scientific literature. Further prospective studies are needed to identify risk factors and unravel possible effects on survival.